Haematopoietic stem cell transplantation for the management of haemoglobinopathies in Greek patients

Transfusion Science

Volumn 23, Issue 3, 2000, Pages 263-264

  Peristeri, J ^a   Kitra, V ^a   Goussetis, E ^a   Petropoulos, D ^a   Theodosaki, M ^a   Kattamis, A ^a   Graphakos, S ^a  

^a Haemophilia Haemostasis Unit   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HEMOGLOBIN; LYMPHOCYTE ANTIBODY; METHOTREXATE;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; BETA THALASSEMIA; BONE MARROW APLASIA; BRAIN HEMORRHAGE; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; GREECE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HUMAN; MALE; PERIPHERAL BLOOD STEM CELL; THROMBOCYTE TRANSFUSION; TOXOPLASMOSIS; UMBILICAL CORD BLOOD;

BETA-THALASSEMIA; GREECE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033693842     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(00)00103-X     Document Type: Conference Paper

References (3)

1. Current status of thalassemia and the sickle cell syndromes in Greece
2. A more immunosuppressive pre-transplant conditioning may be required for Chinese patients with thalassaemia
3. Second marrow transplants for graft failure in patients with thalassemia